Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel antihyperglycemic agent reduces hepatic glucose production

Aug. 8, 2005

Lilly reports phase III results for ruboxistaurin mesilate

Aug. 8, 2005

Ghrelin increases acute energy intake in malnourished peritoneal dialysis patients

Aug. 4, 2005

Human Genome Sciences receives milestone payment for GSK-716155

Aug. 4, 2005

Novel agents disclosed for the treatment of diabetes and related disorders

Aug. 3, 2005

Final phase I data on the effects and safety of Proellex in uterine fibroids

Aug. 3, 2005

HX-531 pretreatment improves responses to leptin

Aug. 3, 2005

Indevus inlicenses Nebido U.S. rights

Aug. 3, 2005

Novel HMG-CoA reductase inhibitors for lipoprotein disorders emerge from Bristol-Myers Squibb R&D

Aug. 2, 2005

BLA filed for Myozyme in Pompe disease

Aug. 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...